Strategic Investment and Leadership Transition Set to Further Propel MaximBio’s Growth ROCKVILLE, Md., July 29, 2024 /PRNewswire/ — Maxim Biomedical, Inc., one of the nation’s leading end-to-end rapid diagnostic test developers and manufacturers, has received a new minority investment…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.